These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 33137632

  • 1. Dual/double pathology in neurocysticercosis causing drug resistant epilepsy - Chance association or causal?
    Mhatre R, Poyuran R, Arimappamagan A, Sinha S, Kulanthaivelu K, Kenchaiah R, Ajay A, Chowdary RM, Saini J, Bharath RD, Zanzmera P, Seetharam R, Sadashiva N, Jamuna R, Satishchandra P, Malla BR, Sk S, Anita M.
    Epilepsy Res; 2020 Dec; 168():106472. PubMed ID: 33137632
    [Abstract] [Full Text] [Related]

  • 2. Understanding the association of neurocysticercosis and mesial temporal lobe epilepsy and its impact on the surgical treatment of patients with drug-resistant epilepsy.
    Bianchin MM, Velasco TR, Wichert-Ana L, Dos Santos AC, Sakamoto AC.
    Epilepsy Behav; 2017 Nov; 76():168-177. PubMed ID: 28462844
    [Abstract] [Full Text] [Related]

  • 3. Pathology-Based Approach to Seizure Outcome After Surgery for Pharmacoresistant Medial Temporal Lobe Epilepsy.
    Martinoni M, Berti PP, Marucci G, Rubboli G, Volpi L, Riguzzi P, Marliani F, Toni F, Bisulli F, Tinuper P, Michelucci R, Baruzzi A, Giulioni M.
    World Neurosurg; 2016 Jun; 90():448-453. PubMed ID: 26968448
    [Abstract] [Full Text] [Related]

  • 4. Type IIB focal cortical dysplasia with balloon cells in medial temporal lobe epilepsy: Clinical, neuroimaging, and histopathological findings.
    Mao C, Jin L, Dou W, Lu Q, Zhou L, Ren H, Zhao Y, Feng F, Guo Y, Gao J.
    Epilepsy Res; 2019 Nov; 157():106189. PubMed ID: 31472401
    [Abstract] [Full Text] [Related]

  • 5. Clinical, imaging, and immunohistochemical characteristics of focal cortical dysplasia Type II extratemporal epilepsies in children: analyses of an institutional case series.
    Knerlich-Lukoschus F, Connolly MB, Hendson G, Steinbok P, Dunham C.
    J Neurosurg Pediatr; 2017 Feb; 19(2):182-195. PubMed ID: 27885945
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of mesial temporal lobe epilepsy associated with hippocampal sclerosis plus neurocysticercosis.
    Bianchin MM, Velasco TR, Wichert-Ana L, Alexandre V, Araujo D, dos Santos AC, Carlotti CG, Takayanagui OM, Sakamoto AC.
    Epilepsy Res; 2014 Dec; 108(10):1889-95. PubMed ID: 25306064
    [Abstract] [Full Text] [Related]

  • 7. Impact of focal cortical dysplasia Type IIIa on seizure outcome following anterior mesial temporal lobe resection for the treatment of epilepsy.
    Dührsen L, Sauvigny T, House PM, Stodieck S, Holst B, Matschke J, Schön G, Westphal M, Martens T.
    J Neurosurg; 2018 Jun; 128(6):1668-1673. PubMed ID: 28753112
    [Abstract] [Full Text] [Related]

  • 8. Occult focal cortical dysplasia may predict poor outcome of surgery for drug-resistant mesial temporal lobe epilepsy.
    Nowak A, Bala A.
    PLoS One; 2021 Jun; 16(9):e0257678. PubMed ID: 34591859
    [Abstract] [Full Text] [Related]

  • 9. Update on Cysticercosis Epileptogenesis: the Role of the Hippocampus.
    Del Brutto OH, Engel J, Eliashiv DS, García HH.
    Curr Neurol Neurosci Rep; 2016 Jan; 16(1):1. PubMed ID: 26659841
    [Abstract] [Full Text] [Related]

  • 10. Focal Cortical Dysplasia IIIa in Hippocampal Sclerosis-Associated Epilepsy: Anatomo-Electro-Clinical Profile and Surgical Results From a Multicentric Retrospective Study.
    Cossu M, d'Orio P, Barba C, Asioli S, Cardinale F, Casciato S, Caulo M, Colicchio G, Consales A, D'Aniello A, De Benedictis A, De Palma L, Didato G, Di Gennaro G, Di Giacomo R, Esposito V, Guerrini R, Nichelatti M, Revay M, Rizzi M, Vatti G, Villani F, Zamponi N, Tassi L, Marras CE.
    Neurosurgery; 2021 Jan 13; 88(2):384-393. PubMed ID: 32860416
    [Abstract] [Full Text] [Related]

  • 11. The role of histopathologic subtype in the setting of hippocampal sclerosis-associated mesial temporal lobe epilepsy.
    Gales JM, Jehi L, Nowacki A, Prayson RA.
    Hum Pathol; 2017 May 13; 63():79-88. PubMed ID: 28322853
    [Abstract] [Full Text] [Related]

  • 12. Clinical and electrophysiological findings in mesial temporal lobe epilepsy with hippocampal sclerosis, based on the recent histopathological classifications.
    Tezer FI, Xasiyev F, Soylemezoglu F, Bilginer B, Oguz KK, Saygi S.
    Epilepsy Res; 2016 Nov 13; 127():50-54. PubMed ID: 27561188
    [Abstract] [Full Text] [Related]

  • 13. Calcified neurocysticercosis lesions and antiepileptic drug-resistant epilepsy: a surgically remediable syndrome?
    Rathore C, Thomas B, Kesavadas C, Abraham M, Radhakrishnan K.
    Epilepsia; 2013 Oct 13; 54(10):1815-22. PubMed ID: 24032594
    [Abstract] [Full Text] [Related]

  • 14. Neuroimaging observations linking neurocysticercosis and mesial temporal lobe epilepsy with hippocampal sclerosis.
    Bianchin MM, Velasco TR, Wichert-Ana L, Araújo D, Alexandre V, Scornavacca F, Escorsi-Rosset SR, dos Santos AC, Carlotti CG, Takayanagui OM, Sakamoto AC.
    Epilepsy Res; 2015 Oct 13; 116():34-9. PubMed ID: 26354165
    [Abstract] [Full Text] [Related]

  • 15. Short- and long-term surgical outcomes of temporal lobe epilepsy associated with hippocampal sclerosis: Relationships with neuropathology.
    Deleo F, Garbelli R, Milesi G, Gozzo F, Bramerio M, Villani F, Cardinale F, Tringali G, Spreafico R, Tassi L.
    Epilepsia; 2016 Feb 13; 57(2):306-15. PubMed ID: 26676889
    [Abstract] [Full Text] [Related]

  • 16. Calcified neurocysticercosis lesions and hippocampal sclerosis: potential dual pathology?
    Rathore C, Thomas B, Kesavadas C, Radhakrishnan K.
    Epilepsia; 2012 Apr 13; 53(4):e60-2. PubMed ID: 22242912
    [Abstract] [Full Text] [Related]

  • 17. Dual pathology in a patient with temporal lobe epilepsy associated with neocortical glial scar after brain abscess and end folium sclerosis/hippocampal sclerosis type 3.
    Miyata H, Sudo S, Kuwashige H, Miyao S, Nakamoto H, Kubota Y, Yoshida Y.
    Neuropathology; 2021 Feb 13; 41(1):42-48. PubMed ID: 33094499
    [Abstract] [Full Text] [Related]

  • 18. Proteomic profile differentiating between mesial temporal lobe epilepsy with and without hippocampal sclerosis.
    Furukawa A, Kakita A, Chiba Y, Kitaura H, Fujii Y, Fukuda M, Kameyama S, Shimada A.
    Epilepsy Res; 2020 Dec 13; 168():106502. PubMed ID: 33197783
    [Abstract] [Full Text] [Related]

  • 19. From seizures to epilepsy and its substrates: neurocysticercosis.
    Singh G, Burneo JG, Sander JW.
    Epilepsia; 2013 May 13; 54(5):783-92. PubMed ID: 23621876
    [Abstract] [Full Text] [Related]

  • 20. The impact of epilepsy duration in a series of patients with mesial temporal lobe epilepsy due to unilateral hippocampal sclerosis.
    Duarte JTC, Jardim AP, Comper SM, De Marchi LR, Gaça LB, Garcia MTFC, Sandim GB, Assunção-Leme IB, Carrete H, Centeno RS, Lancellotti CLP, Jackowski AP, Cavalheiro EA, Guaranha MSB, Yacubian EMT.
    Epilepsy Res; 2018 Nov 13; 147():51-57. PubMed ID: 30248630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.